ArticleCell reports. Medicine2024

Targeting miR-29 mitigates skeletal senescence and bolsters therapeutic potential of mesenchymal stromal cells.

Zhen Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.